Back
Novo Nordisk A/S Vs. Eli Lilly and Industry Stock Comparison
Buy
76
NONOF
Novo Nordisk A/S
Last Price:
128.75
Seasonality Move:
4.69%
Buy
68
LLY
Eli Lilly and
Last Price:
760.14
Seasonality Move:
2.06%
Buy
76
Novo Nordisk A/S (NONOF)
is a Buy
Is Novo Nordisk A/S a Buy, Sell or Hold?
- The current Novo Nordisk A/S [NONOF] share price is $127.72. The Score for NONOF is 76, which is 52% above its historic median score of 50, and infers lower risk than normal.
- NONOF is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
68
Eli Lilly and (LLY)
is a Buy
Is Eli Lilly and a Buy, Sell or Hold?
- The current Eli Lilly and [LLY] share price is $771.55. The Score for LLY is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
- LLY is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NONOF Stock Price Chart
What is Novo Nordisk A/S's stock price today?
-
The Novo Nordisk A/S share price today is $127.72
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NONOF is experiencing slight selling pressure.
LLY Stock Price Chart
What is Eli Lilly and's stock price today?
-
The Eli Lilly and share price today is $771.55
The current trend is moderately bullish and LLY is experiencing selling pressure, which indicates risk of future bearish movement.
NONOF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.01 | Buy |
| Relative Strength Index (14 RSI): | 54.66 | Buy |
| Chaikin Money Flow: | -351 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (123 - 126.82) | Buy |
| Bollinger Bands (100): | (108.67 - 129.21) | Buy |
LLY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.79 | Buy |
| Relative Strength Index (14 RSI): | 54.82 | Buy |
| Chaikin Money Flow: | -1480376 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (736.2 - 772.36) | Buy |
| Bollinger Bands (100): | (640.06 - 781.9) | Buy |
NONOF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 125.58 | Buy |
| 20-day SMA: | 124.99 | Buy |
| 50-day SMA: | 126.98 | Buy |
| 200-day SMA: | 106.86 | Buy |
| 8-day EMA: | 125.65 | Buy |
| 20-day EMA: | 125.47 | Buy |
| 50-day EMA: | 124.32 | Buy |
| 200-day EMA: | 108.74 | Buy |
LLY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 767.47 | Buy |
| 20-day SMA: | 750.84 | Buy |
| 50-day SMA: | 761.38 | Buy |
| 200-day SMA: | 636.6 | Buy |
| 8-day EMA: | 764.5 | Buy |
| 20-day EMA: | 758.14 | Buy |
| 50-day EMA: | 748.25 | Buy |
| 200-day EMA: | 643.87 | Buy |
Novo Nordisk A/S Earnings Growth & NONOF Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.52 per share, and an increase next year of $0.55 per share.
Eli Lilly and Earnings Growth & LLY Earnings Dates
- Analysts estimate an earnings increase this quarter of $3.91 per share, a decrease next quarter of $0.30 per share, an increase this year of $7.44 per share, and an increase next year of $5.12 per share.
Novo Nordisk A/S Technical Analysis
| Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Eli Lilly and Technical Analysis
| Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||